TBXT and cancer: In addition, T-DXd, an antibody-drug conjugate widely used to treat various cancers, is thought to be non-specifically taken up by alveolar macrophages via Fcγ receptors, releasing DXd within lung tissue, where it accumulates and causes alveolar damage (30).